Downregulation of serum metabolite GTA-446 as a novel potential marker for early detection of colorectal cancer

BACKGROUND: We previously reported that GTA-446 may be a useful biomarker for early detection of colorectal cancer. In the present study, we confirmed the clinical feasibility of GTA-446 as a screening tool for colorectal cancer with a novel measurement system developed for clinical use. We also imp...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Br J Cancer
Päätekijät: Hata, Tsuyoshi, Takemasa, Ichiro, Takahashi, Hidekazu, Haraguchi, Naotsugu, Nishimura, Junichi, Hata, Taishi, Mizushima, Tsunekazu, Doki, Yuichiro, Mori, Masaki
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group 2017
Aiheet:
Molecular Diagnostics
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5520513/
https://ncbi.nlm.nih.gov/pubmed/28632728
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2017.163
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia